NEW YORK (
Bristol-Myers Squibb Company
) hit a new 52-week high Tuesday as it is currently trading at $28.04, above its previous 52-week high of $28 with 3.5 million shares traded as of 11:46 a.m. ET. Average volume has been 12.9 million shares over the past 30 days.
Bristol-Myers Squibb has a market cap of $47.4 billion and is part of the
industry. Shares are up 3.7% year to date as of the close of trading on Monday.
Bristol-Myers Squibb Company, a global biopharmaceutical company, discovers, develops, and delivers innovative medicines that help patients prevail over serious diseases. The company has a P/E ratio of 15.5, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 16.7.
- Practice your BMY trading strategies and win cash in our stock game.
TheStreet Ratings rates Bristol-Myers Squibb as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full
52-week high stocks
or get investment ideas from our